Disclosure: We earn commissions on purchases made through our links. This never influences our scores. Editorial policy
D-Chiro-Inositol
D-chiro-inositol was the original PCOS inositol, and the field has moved on.
- Evidence
- Likely Effective
- Category
- Women's Health
- Best form
- 40:1 myo-inositol to D-chiro-inositol combination (Theralogix Ovasitol and similar, the modern standard for PCOS)
- Effective dose
- Most modern protocols use 50-100 mg/day of D-chiro-inositol alongside 2-4 g of myo-inositol (the 40:1 ratio). Older DCI-alone trials used 600-1200 mg/day, but high-dose DCI alone has fallen out of favor and is not recommended in fertility contexts.
- Lab tested
- 3 of 6 products
- Category
- Women's Health
- Best form
- 40:1 myo-inositol to D-chiro-inositol combination (Theralogix Ovasitol and similar, the modern standard for PCOS)
- Effective dose
- Most modern protocols use 50-100 mg/day of D-chiro-inositol alongside 2-4 g of myo-inositol (the 40:1 ratio). Older DCI-alone trials used 600-1200 mg/day, but high-dose DCI alone has fallen out of favor and is not recommended in fertility contexts.
- Lab tested
- 3 of 6 products
Key takeaways
- →40:1 myo-to-DCI is the modern PCOS standard, not DCI alone, for almost all readers.
- →More DCI is not better: the DCI paradox suggests high doses can impair oocyte quality during fertility treatment.
- →Standalone DCI still has a niche in lean PCOS and clinician-supervised insulin support, but rarely as a first move.
- →If you came here looking for DCI, a 40:1 product like Ovasitol is probably what you actually want.
What Is D-Chiro-Inositol?
D-chiro-inositol was the original PCOS inositol, and the field has moved on. The 1999 Nestler trial in the New England Journal of Medicine showed 1200 mg/day of DCI for 6-8 weeks restored ovulation in 19 of 22 PCOS women versus 6 of 22 on placebo, lowered free testosterone, and improved insulin response. Iuorno 2004 reproduced the effect in lean PCOS women at 600 mg/day. For about a decade those papers anchored the entire DCI marketing story. The problem is that newer evidence favors the 40:1 myo-to-DCI ratio at much lower DCI exposure, and most clinicians now reach for Ovasitol-style products rather than DCI-alone capsules.
The reason is the "DCI paradox" described by Carlomagno, Unfer, and Roseff in Fertility and Sterility in 2011. PCOS ovaries appear to over-express the insulin-dependent epimerase that converts myo-inositol to D-chiro-inositol, creating a local myo-inositol deficiency in the follicle even when systemic DCI levels are fine. Adding more DCI on top of this can worsen oocyte quality. Isabella and Raffone's 2012 ICSI trial directly compared myo-inositol against high-dose DCI in IVF cycles and found myo-inositol produced more mature oocytes and better-quality embryos. So while DCI helps insulin signaling in muscle and liver, the ovary itself wants myo-inositol, and dumping in extra DCI can backfire on fertility.
This is why the modern PCOS standard is the 40:1 ratio at 4 g/day total (so 4 g myo plus 100 mg DCI), which delivers a tiny physiological dose of DCI and a clinically meaningful dose of myo. The Unfer 2017 meta-analysis and Nordio 2019 head-to-head ratio comparison both support this approach. Standalone DCI capsules are mostly a legacy category at this point. If you are taking DCI by itself today, the niches that still make sense are: lean PCOS without infertility goals (where Iuorno 2004 still applies), augmenting an existing 40:1 base with extra DCI for stubborn insulin resistance under clinician supervision, or non-PCOS metabolic syndrome research, where the data is thin.
Most readers who land here looking for D-chiro-inositol actually want the 40:1 product, which is why we list the umbrella inositol page and the myo-inositol sister profile prominently above. Dosing standalone DCI above 600 mg/day in women trying to conceive is specifically not recommended on the current evidence. If you are pregnant or actively trying to conceive, talk to your OB before adding standalone DCI to a regimen.
Does It Work? The Evidence
How A-F grades workOvulation and insulin sensitivity in PCOS (high-dose DCI alone)
Nestler et al. 1999 NEJM (n=44, 1200 mg/day for 6-8 weeks): ovulation restored in 19/22 vs 6/22 placebo, free testosterone and insulin response improved; Iuorno et al. 2004 in lean PCOS (n=20, 600 mg/day): reduced circulating insulin and androgens; replication in larger modern trials has been limited as the field shifted to 40:1 ratio products
Oocyte quality at high DCI doses (the DCI paradox)
Carlomagno, Unfer, Roseff 2011 Fertil Steril hypothesis paper articulating the DCI paradox; Isabella & Raffone 2012 ICSI trial (n=54): myo-inositol produced more mature oocytes and higher-quality embryos than 1200 mg/day DCI; Sacchi et al. 2016 follicular fluid analysis showing PCOS ovaries have flipped myo:DCI ratio
PCOS metabolic markers at the 40:1 ratio (low DCI, ~100 mg/day)
Unfer et al. 2017 meta-analysis of 9 RCTs (n=496): improved fasting insulin, HOMA-IR, SHBG; Nordio et al. 2019 7-arm trial directly comparing ratios: 40:1 was the most effective; Fitz et al. 2024 PCOS guideline meta-analysis (30 trials) reaffirms benefit
Hyperandrogenism and acne
Extrapolated from PCOS testosterone reductions in the Nestler 1999 and Iuorno 2004 trials; no direct acne or skin endpoint trials of DCI alone
Lean PCOS phenotype
Iuorno et al. 2004 specifically in lean PCOS women (BMI 20-24): 600 mg/day improved insulin and androgen markers; lean PCOS may respond differently from classic obese-insulin-resistant phenotype, but trial replication is sparse
Insulin sensitivity in non-PCOS metabolic syndrome
Mechanistic plausibility from second-messenger biology, but no well-powered trials of DCI alone in non-PCOS metabolic syndrome populations
| Grade | Claimed Benefit | Key Studies | Our Verdict |
|---|---|---|---|
| B | Ovulation and insulin sensitivity in PCOS (high-dose DCI alone) | Nestler et al. 1999 NEJM (n=44, 1200 mg/day for 6-8 weeks): ovulation restored in 19/22 vs 6/22 placebo, free testosterone and insulin response improved; Iuorno et al. 2004 in lean PCOS (n=20, 600 mg/day): reduced circulating insulin and androgens; replication in larger modern trials has been limited as the field shifted to 40:1 ratio products | Early Signal |
| B | Oocyte quality at high DCI doses (the DCI paradox) | Carlomagno, Unfer, Roseff 2011 Fertil Steril hypothesis paper articulating the DCI paradox; Isabella & Raffone 2012 ICSI trial (n=54): myo-inositol produced more mature oocytes and higher-quality embryos than 1200 mg/day DCI; Sacchi et al. 2016 follicular fluid analysis showing PCOS ovaries have flipped myo:DCI ratio | Conflicted |
| A | PCOS metabolic markers at the 40:1 ratio (low DCI, ~100 mg/day) | Unfer et al. 2017 meta-analysis of 9 RCTs (n=496): improved fasting insulin, HOMA-IR, SHBG; Nordio et al. 2019 7-arm trial directly comparing ratios: 40:1 was the most effective; Fitz et al. 2024 PCOS guideline meta-analysis (30 trials) reaffirms benefit | Supported |
| C | Hyperandrogenism and acne | Extrapolated from PCOS testosterone reductions in the Nestler 1999 and Iuorno 2004 trials; no direct acne or skin endpoint trials of DCI alone | Early Signal |
| C | Lean PCOS phenotype | Iuorno et al. 2004 specifically in lean PCOS women (BMI 20-24): 600 mg/day improved insulin and androgen markers; lean PCOS may respond differently from classic obese-insulin-resistant phenotype, but trial replication is sparse | Early Signal |
| C | Insulin sensitivity in non-PCOS metabolic syndrome | Mechanistic plausibility from second-messenger biology, but no well-powered trials of DCI alone in non-PCOS metabolic syndrome populations | Not There Yet |
How to Choose: Forms, Doses & What Matters
Clinical dose: Most modern protocols use 50-100 mg/day of D-chiro-inositol alongside 2-4 g of myo-inositol (the 40:1 ratio). Older DCI-alone trials used 600-1200 mg/day, but high-dose DCI alone has fallen out of favor and is not recommended in fertility contexts.
Best forms: 40:1 myo-inositol to D-chiro-inositol combination (Theralogix Ovasitol and similar, the modern standard for PCOS), Standalone D-chiro-inositol capsules (Klaire Labs 150 mg, Neurobiologix 500 mg, Zazzee 50 mg, used either to augment a 40:1 base or for the older Nestler-protocol research dose), Carob-pod-derived D-chiro-inositol (the form used in most clinical trials, distinct from synthetic chiro-inositol)
If you are using a 40:1 ratio product, you do not need to add standalone DCI on top of it. The ~100 mg of DCI in a daily 4 g dose of Ovasitol or equivalent is the physiologically appropriate amount. If you are using standalone DCI under clinician guidance, the older Nestler protocol was 1200 mg once daily for 6-8 weeks (or 600 mg for lean PCOS), with effects on insulin and ovulation appearing in roughly 8 weeks. Take with or without food. Cycle regularity in PCOS may take 3-6 months. Do not exceed 600 mg/day if you are trying to conceive without explicit medical advice.
Who Should Take D-Chiro-Inositol?
Women with lean PCOS who have responded poorly to a 40:1 ratio product alone and want to add a small standalone DCI dose under clinician supervision. People specifically reproducing the older Nestler protocol under medical guidance. People who already use a 40:1 base and want to layer additional DCI for stubborn insulin resistance with their endocrinologist's input. For the vast majority of PCOS readers, the 40:1 ratio is the better starting point and standalone DCI is unnecessary.
Who Should Avoid It?
Not for everyone
Side Effects & Safety
Product Scores
6 products scored on dosing accuracy, third-party testing, cost per effective dose, and label transparency.
The Scorecard: 6 Products Compared
Ovasitol Inositol Powder, 90-Day Supply (40:1 Myo + DCI)
Theralogix
$75.00 ÷ 90 days at 100mg/day (2 servings × 50mg)
If you came here looking for D-chiro-inositol, this is almost certainly what you actually want. The 40:1 ratio is the modern standard; standalone DCI capsules are now a niche category.
Prices checked 2026-04-28. Cost shown is per clinically effective daily dose, not per pill.
Myo-Inositol & D-Chiro Inositol Powder (40:1)
Wholesome Story
$29.99 ÷ 45 days at 100mg/day (2 servings × 50mg)
The value pick if you accept that the 40:1 ratio is what most DCI shoppers actually want
Prices checked 2026-04-28. Cost shown is per clinically effective daily dose, not per pill.
D-Chiro-Inositol 150 mg, 60 Capsules
Klaire Labs
$33.00 ÷ 60 days at 150mg/day (1 serving × 150mg)
The most defensible standalone DCI on the market. The 150 mg dose is small enough to layer on top of a 40:1 base without pushing total DCI exposure into DCI-paradox territory during fertility treatment.
Prices checked 2026-04-28. Cost shown is per clinically effective daily dose, not per pill.
D-Chiro-Inositol 50 mg, 90 Vegan Capsules
Zazzee
$17.99 ÷ 90 days at 50mg/day (1 serving × 50mg)
The smallest standalone DCI dose on Amazon, well-suited to a custom 40:1 stack with a pure myo-inositol powder
Prices checked 2026-04-28. Cost shown is per clinically effective daily dose, not per pill.
DCI 500 mg, 60 Vegetable Capsules
Neurobiologix
$56.95 ÷ 60 days at 500mg/day (1 serving × 500mg)
Reasonable for clinician-supervised use targeting the Nestler 1999 protocol in non-fertility PCOS contexts; not a first move for most PCOS readers
Prices checked 2026-04-28. Cost shown is per clinically effective daily dose, not per pill.
Inositol Complex (3.6:1 Myo to DCI)
Pure Encapsulations$38.40 ÷ 30 days at 300mg/day (2 servings × 150mg)
Listed for completeness because it shows up on Amazon next to other DCI products. The 40:1 ratio is the better evidence-based choice for almost everyone.
Prices checked 2026-04-28. Cost shown is per clinically effective daily dose, not per pill.
Full Comparison
| Category | Ovasitol Inositol Powder, 90-Day Supply (40:1 Myo + DCI) Theralogix | Myo-Inositol & D-Chiro Inositol Powder (40:1) Wholesome Story | D-Chiro-Inositol 150 mg, 60 Capsules Klaire Labs | D-Chiro-Inositol 50 mg, 90 Vegan Capsules Zazzee | DCI 500 mg, 60 Vegetable Capsules Neurobiologix | Inositol Complex (3.6:1 Myo to DCI) Pure Encapsulations |
|---|---|---|---|---|---|---|
| Brand Score | 95/100Winner | 88/100 | 84/100 | 78/100 | 75/100 | 72/100 |
| Dosing & Form | 25/25Winner | 25/25 | 22/25 | 19/25 | 19/25 | 14/25 |
| Purity | 25/25Winner | 19/25 | 22/25 | 17/25 | 17/25 | 22/25 |
| Value | 22/25Winner | 22/25 | 17/25 | 19/25 | 16/25 | 13/25 |
| Transparency | 23/25Winner | 22/25 | 23/25 | 23/25 | 23/25 | 23/25 |
| Cost/Day | $0.83 | $0.67 | $0.55 | $0.20Winner | $0.95 | $1.28 |
| Dose/Serving | 50mg | 50mg | 150mg | 50mg | 500mg | 150mg |
| Form | Myo-Inositol + D-Chiro-Inositol (40:1) Powder | Myo-Inositol + D-Chiro-Inositol (40:1) Powder | D-Chiro-Inositol Capsule (carob-derived) | D-Chiro-Inositol Capsule | D-Chiro-Inositol Capsule | Myo-Inositol + D-Chiro-Inositol (3.6:1) Capsule |
| Third-Party Tested | ✓ Yes | ✓ Yes | No | No | No | ✓ Yes |
| Proprietary Blend | No | No | No | No | No | No |
Frequently Asked Questions
DCI vs myo-inositol vs the 40:1 ratio, which one should I take?
For PCOS, the 40:1 myo-to-DCI ratio is the modern standard and is what we recommend most readers start with. It mimics the body's natural plasma ratio and has the strongest meta-analytic support. Pure myo-inositol alone is the right pick for the high-dose anxiety and panic disorder use case (12-18 g/day). Standalone DCI is a niche choice today, mostly for lean PCOS or clinician-led adjunctive use. See our umbrella inositol page and the myo-inositol profile for the full picture.
Is more D-chiro-inositol better?
No, and this is the most important counter-intuitive finding in the DCI literature. The DCI paradox, articulated by Carlomagno and Unfer in 2011, suggests that PCOS ovaries already over-convert myo-inositol to DCI inside the follicle, and adding extra DCI on top can worsen oocyte quality. The Isabella 2012 ICSI trial showed myo-inositol outperformed high-dose DCI for embryo quality. More is not better, and during fertility treatment more is potentially harmful.
Do I need DCI alone or just an Ovasitol-style product?
For nearly everyone with PCOS, a 40:1 product like Theralogix Ovasitol or the Wholesome Story 40:1 powder is what you want. It already contains the right small amount of DCI alongside a clinical dose of myo-inositol. Adding a standalone DCI capsule on top is rarely beneficial and can be counterproductive at higher doses. The exception is clinician-supervised use in specific phenotypes.
Lean vs overweight PCOS, does it matter for DCI?
Possibly. The lean PCOS phenotype tends to have a different insulin and androgen profile from the classic overweight-insulin-resistant phenotype, and the Iuorno 2004 trial in lean women specifically showed benefit at 600 mg/day. Some clinicians use this as a rationale for trying standalone DCI in lean PCOS. The data is far from definitive, and a 40:1 product is still a reasonable first-line for both phenotypes. This is a conversation to have with your reproductive endocrinologist.
Can I take DCI while trying to conceive?
Standalone DCI above roughly 600 mg/day is generally not recommended during fertility treatment because of the oocyte-quality concerns from the DCI paradox literature. The small amount of DCI in a 40:1 myo-DCI product (around 100 mg/day) has been used during pre-conception protocols without harm signals. If you are doing IVF or ICSI, talk to your reproductive endocrinologist before taking any standalone DCI.
How long does D-chiro-inositol take to work?
In the Nestler 1999 trial, ovulation and insulin endpoints improved at 6-8 weeks. Most modern PCOS inositol trials run 12-24 weeks before judging response. Cycle regularity in PCOS often takes 3-6 months on any inositol protocol. Do not expect immediate effects, and do not stop after 4 weeks if nothing has changed.
What is the safest way to add DCI on top of a 40:1 product?
Under clinician supervision, the typical augmentation strategy is a 40:1 base at 4 g/day plus a low standalone DCI dose (50-150 mg). This keeps total DCI exposure modest while addressing residual insulin resistance. Klaire Labs makes a 150 mg standalone capsule that is commonly used this way. We do not recommend stacking high-dose DCI (500-1200 mg) on top of a 40:1 product without medical advice, especially during fertility treatment.
Sources
- Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314-20.
- Iuorno MJ, Jakubowicz DJ, Baillargeon JP, et al. Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract. 2002;8(6):417-23.
- Carlomagno G, Unfer V, Roseff S. The D-chiro-inositol paradox in the ovary. Fertil Steril. 2011;95(8):2515-6.
- Isabella R, Raffone E. Does ovary need D-chiro-inositol? Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. J Ovarian Res. 2012;5:14.
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647-658.
- Nordio M, Basciani S, Camajani E. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci. 2019;23(12):5512-5521.
- Fitz V, Graca S, Mahalingaiah S, et al. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab. 2024;109(6):1630-1655.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products discussed on this page are not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any supplement regimen.